动脉压迫止血器在冠状动脉造影术后的应用

Application of Arterial Compression Hemostasis after Coronary Arteriography

目的评价经股动脉冠状动脉造影术(coronary arteriography,CAG)后股动脉穿刺部位应用YM-GU-1229型股动脉压迫器的止血效果和安全性。方法经股动脉途径行CAG的195例患者随机分为两组,观察组术后采用天津怡美医疗器械有限公司生产的YM-GU-1229型动脉压迫器压迫止血105例,对照组采用传统人工压迫止血法90例,比较两组止血时间、制动时间和血管并发症发生率。结果两组止血方法进行比较,其中止血时间观察组为(3.0±1.5)min,对照组为(20.0±4.5)min;下肢制动时间观察组为(8.5±2.5)h,对照组为(22.0±2.0)h,两组比较观察组止血时间及下肢制动时间均显著缩短(P<0.05)。观察组血管并发症的发生率为6.7%,人工压迫组为12.2%,两组比较,观察组发生率明显减少(P<0.05);止血成功率两组间无明显差异(P>0.05)。结论 YM-GU-1229型动脉压迫止血器压迫止血可有效缩短止血时间及下肢制动时间,操作简便,适用性广,血管并发症明显低于传统人工压迫止血法,值得临床推广。

Objective To assess the safety and efficacy of YM-GU-1229 femoral arterial compression hemostasis which was applied on femoral artery puncture site after coronary angiography（CAG）.Methods A total of 195 patients with CAG through femoral artery path were randomly assigned into the experimental group（n=105） treated with femoral artery compression device（FACD） of YM-GU-1229,which were produced by Tianjin Ymir Medical CO.LTD and the control group（n=90） treated with the routine manual compression hemostasis.The hemostasis time,braking time and the incidence of vascular complications were compared between the two groups.Results A comparison was conducted on the hemostasis methods between the two groups.The hemostasis time in the experimental group and the control group were（3.0±1.5）min and（20±4.5）min respectively.The braking time of lower limbs in the experimental group and the control group were（8.5±2.5）h and（22.0±2.0）h respectively.The hemostasis time and braking time of lower limbs were significantly decreased in the two experimental groups（P0.05）.The incident of vascular complications in the experimental group（6.7%） was significantly less than that（12.2%） in the control group（P0.05）.No significant difference was observed on the success rate of hemostasis between the two groups（P0.05）.Conclusion YM-GU-1229 FACD could significantly shorten the hemostasis time and braking time of low limbs.The procedure is convenient and its serviceable range is wide.Meanwhile the incidence of vascular complications is significantly lower with YM-GU-1229 FACD than traditional manual compression and it is worth extending in clinical practice.